Cost of Revenue in USD of NKGen Biotech, Inc. from Q3 2022 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
NKGen Biotech, Inc. quarterly and annual Cost of Revenue history and change rate from Q3 2022 to 2023.
  • NKGen Biotech, Inc. Cost of Revenue for the quarter ending 30 Sep 2023 was $0.
  • NKGen Biotech, Inc. annual Cost of Revenue for 2023 was $0, a 100% decline from 2022.
Source SEC data
View on sec.gov
Cost of Revenue, Quarterly (USD)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Change (%)

NKGen Biotech, Inc. Quarterly Cost of Revenue (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2023 $0 $0 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q3 2022 $0 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023 2023 Q3

NKGen Biotech, Inc. Annual Cost of Revenue (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $0 -$18,000 -100% 01 Jan 2023 31 Dec 2023 10-K 16 Apr 2024 2023 FY
2022 $18,000 01 Jan 2022 31 Dec 2022 10-K 16 Apr 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.